Skip to main content
. Author manuscript; available in PMC: 2018 Oct 10.
Published in final edited form as: J Control Release. 2016 Dec 24;263:139–150. doi: 10.1016/j.jconrel.2016.12.025

Fig. 1.

Fig. 1

SEC analysis of (A) Fab′1F5 fragment (Fab′1F5-SH) of 1F5 mAb and the Fab′1F5-MORF1 conjugates with different MORF1 sequences. Sephacryl S-100 HR16/60 column with PBS as the mobile phase; (B) P1-TT and P1-(MORF2)x conjugates with different MORF2 sequences. Superose 6 HR10/30 column with sodium acetate buffer (pH 6.5) and 30% acetonitrile (v/v) as the mobile phase.